Clinical Trials

Showing 201 - 220 of 487 trials
Title Investigatorsort icon Disease(s)
Treatment of Children with All Stages of Hepatoblastoma
[Protocol 10-046]
Kobos, Rachel
  • Hepatobiliary
    • Liver Cancer
A Phase I Study of WT1-Specific Donor-Derived T Cells in Patients with Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia after T-Cell-Depleted Allogeneic Stem Cell Transplantation
Relapsed/Refractory
[Protocol 12-175]
Koehne, Guenther
  • Hematology
    • Multiple Myeloma
A Pilot Study of the Wilms' Tumor 1 (WT1) Analog Peptide Vaccine in Patients with Multiple Myeloma after Autologous Stem Cell Transplantation
[Protocol 12-288]
Koehne, Guenther
  • Hematology
    • Multiple Myeloma
A Phase II Study of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post-Transplantation Donor Lymphocyte Infusions for Patients with Relapsed or High-Risk Multiple Myeloma
[Protocol 10-051]
Koehne, Guenther
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Hematology
    • Multiple Myeloma
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
[Protocol 10-031]
Kollmeier, Marisa
  • Bladder Cancer
Phase I Study of Olaparib in Combination with Chemotherapy in Patients Newly Diagnosed with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 10-220]
Konner, Jason
  • Ovarian Cancer
A Phase IB Study of REGN910 and Aflibercept plus Paclitaxel in Women with Recurrent Ovarian Cancer
[Protocol 13-156]
Konner, Jason
  • Ovarian Cancer
A Phase III Study of AEZS-108 versus Doxorubicin as Second-Line Therapy for Recurrent or Metastatic Endometrial Cancer
[Protocol 13-130]
Konner, Jason
  • Uterine (Endometrial) Cancer
A Study of Vorinostat (SAHA) plus Isotretinoin and Chemotherapy in Infants and Young Children with Embryonal Tumors of the Central Nervous System
[Protocol 12-191]
Kramer, Kim
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of Intrathecal Radioimmunotherapy Using 131I-8H9 for Central Nervous System/Leptomeningeal Cancers
[Protocol 03-133]
Kramer, Kim
  • Brain Tumors, Primary
  • Neuroblastoma
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase II Study of Intrathecal I131-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
[Protocol 05-122]
Kramer, Kim
  • Brain Tumors, Metastatic
  • Brain Tumors, Primary
    • Brain Metastases
  • Neuroblastoma
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase II Study of Neratinib Alone and with Temsirolimus in Patients with Non-Small Cell Lung Cancer with HER2 Mutations
[Protocol 13-087]
Kris, Mark
  • Lung Cancer, Non-Small Cell
A Phase II Study of Tremelimumab versus Placebo for Previously Treated Inoperable Mesothelioma
[Protocol 13-092]
Krug, Lee
  • Mesothelioma
A Phase II Study of WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma
[Protocol 10-134]
Krug, Lee
  • Mesothelioma
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
[Protocol 08-053]
Krug, Lee
  • Mesothelioma
A Study Assessing the Use of Dual Handset Phones to Improve Communication with Inpatients Who Have Limited English Proficiency
[Protocol 14-042]
Kumar, Chhavi
  • Breast Cancer
  • Leukemia
  • Lymphoma
  • Quality of Life
  • Solid Tumors
  • Upper Gastrointestinal
Memorial Sloan-Kettering Cancer Center Pancreatic Tumor Registry
[Protocol 02-102]
Kurtz, Robert
  • Hepatobiliary
    • Pancreatic Cancer
  • Hereditary Cancer & Genetics
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma
[Protocol 05-075]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission after Non-Myeloablative Therapy in Patients with High-Risk Neuroblastoma
[Protocol 09-159]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
[Protocol 09-160]
Kushner, Brian
  • Neuroblastoma